Novanta Inc. (NOVTU) exhibits exceptional financial health, highlighted by a strong Piotroski F-Score of 8/9 and a very conservative debt-to-equity ratio of 0.23. While the balance sheet is robust with high liquidity (Current Ratio 3.69), the company faces a disconnect between revenue growth (8.50%) and nearly stagnant earnings growth (0.60%). Despite a positive 1-year price return of 21%, the deterministic scorecard indicates a bearish technical trend and weak insider sentiment (40/100), suggesting a lack of conviction from internal stakeholders.